Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Denver CO, Aurora CO, Lakewood CO, Lone Tree CO,
Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

A Study of PYX-201 in Advanced Solid Tumors

for
Solid Tumor, Advanced Solid Tumor
Location: Denver CO, Scottsdale AZ, Dallas TX, St Louis MO,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT05720117

Phase 1, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Denver CO, Salt Lake City UT, Dallas TX, Austin TX,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase 1, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: Denver CO, Rochester MN, Los Angeles CA, Houston TX,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase 1, Phase 2, Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Denver CO, Dallas TX, Houston TX, Chicago IL, Eugene OR,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for
MTAP-deleted Solid Tumors
Location: Denver CO, Irving TX, San Antonio TX, San Francisco CA,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06914128

Phase 1, Phase 2, Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Denver CO, Aurora CO, Omaha NE, Oklahoma City OK,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for
Smoldering Plasma Cell Myeloma
Location: Denver CO, Englewood CO, Lakewood CO, Thornton CO,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase 3, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Denver CO, Salt Lake City UT, Omaha NE, Goodyear AZ,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase 3, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Denver CO, Omaha NE, El Paso TX, Kansas City KS,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase 3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Denver CO, Albuquerque NM, Wichita KS, Omaha NE,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase 3, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Tucson AZ, Minneapolis MN, Tyler TX,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase 2, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Denver CO, Aurora CO, Kansas City MO, Phoenix AZ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase 3, Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Denver CO, El Paso TX, San Antonio TX, Torrance CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Denver CO, Aurora CO, Wichita KS, Omaha NE, Gilbert AZ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Denver CO, Aurora CO, Lone Tree CO, Salt Lake City UT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase 1, Phase 2, Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Denver CO, Englewood CO, Lakewood CO, Thornton CO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07392892

Phase 2, Phase 3, Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

for
Urothelial Cancer
Location: Denver CO, Edwards CO, Murray UT, St. George UT,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07106762

Phase 2, Phase 3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Denver CO, Oklahoma City OK, Westwood KS, Goodyear AZ,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Denver CO, Albuquerque NM, Omaha NE, Kansas City KS,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting